Should a positive direct antiglobulin test be considered a prognostic predictor in chronic lymphocytic leukemia?
The clinical course of patients with B-cell CLL is often complicated by autoimmune phenomena. The DAT might be positive at some time during the course of the disease in up to 35% of cases. The aim of this retrospective study was to investigate the relationship between the occurrence of a positive DAT and biological features of CLL patients. In our institution, 146 untreated patients with CLL were studied using the DAT. According to the statistical analysis, a high level of β2-microglobulin and unmutated IgHV emerged as factors significantly related to the presence of DAT positivity. Time to first TFS was significantly shorter in DAT-positive patients. The adverse effect of a DAT positive result was maintained in terms of TFS when patients with mutated IgHV status were excluded from statistical analysis. These results suggest that the DAT might provide additional prognostic information regarding patients with IgHV unmutated status.